Research Calls I
-
Upgrades:
- Ally Financial (ALLY) upgraded to Equal-Weight from Underweight at Morgan Stanley; tgt raised to $31
- ArcelorMittal (MT) upgraded to Overweight from Neutral at JP Morgan (yesterday)
- BASF AG (BASFY) upgraded to Buy from Sell at UBS
- C4 Therapeutics (CCCC) upgraded to Buy from Hold at Stifel; tgt raised to $12
- Capital One (COF) upgraded to Equal-Weight from Underweight at Morgan Stanley; tgt raised to $120
- D.R. Horton (DHI) upgraded to Outperform from Mkt Perform at Keefe Bruyette; tgt raised to $164
- Gogoro (GGR) upgraded to Neutral from Underweight at JP Morgan
- Health Catalyst (HCAT) upgraded to Overweight from Neutral at JP Morgan; tgt lowered to $11
- Incyte (INCY) upgraded to Outperform from Market Perform at Leerink Partners; tgt $78
- MFA Financial (MFA) upgraded to Outperform from Mkt Perform at Keefe Bruyette; tgt raised to $12
- Mohawk (MHK) upgraded to Equal Weight from Underweight at Barclays; tgt raised to $100
- MSCI (MSCI) upgraded to Overweight from Equal-Weight at Morgan Stanley; tgt raised to $600
- Opendoor Technologies (OPEN) upgraded to Mkt Perform from Underperform at Keefe Bruyette; tgt $3.50
- Pentair (PNR) upgraded to Overweight from Sector Weight at KeyBanc Capital Markets; tgt $82
- Q2 Holdings (QTWO) upgraded to Neutral from Underweight at Piper Sandler; tgt raised to $41
- Radian Group (RDN) upgraded to Outperform from Mkt Perform at Keefe Bruyette; tgt $29
- Realty Income (O) upgraded to Outperform from Neutral at Exane BNP Paribas; tgt $63
- RxSight (RXST) upgraded to Overweight from Equal Weight at Wells Fargo; tgt raised to $42
- Volkswagen AG (VWAGY) upgraded to Neutral from Underperform at Exane BNP Paribas
- Xponential Fitness (XPOF) upgraded to Buy from Hold at Stifel; tgt $18
-
Downgrades:
- Agree Realty (ADC) downgraded to Neutral from Outperform at Exane BNP Paribas; tgt $64
- Aveanna (AVAH) downgraded to Underweight from Neutral at JP Morgan
- Bread Financial (BFH) downgraded to Underweight from Equal-Weight at Morgan Stanley; tgt lowered to $25
- Church & Dwight (CHD) downgraded to Sell from Neutral at Citigroup; tgt $90
- Coherent (COHR) downgraded to Equal-Weight from Overweight at Morgan Stanley; tgt raised to $45
- Ferrari (RACE) downgraded to Neutral from Outperform at Exane BNP Paribas
- Ferrari (RACE) downgraded to Hold from Buy at HSBC Securities
- Ford Motor (F) downgraded to Neutral from Outperform at Exane BNP Paribas; tgt $12
- Hertz Global (HTZ) downgraded to Perform from Outperform at Oppenheimer
- Hillman Solutions Corp. (HLMN) downgraded to Equal Weight from Overweight at Barclays; tgt $9
- Inspire Medical Systems (INSP) downgraded to Equal Weight from Overweight at Wells Fargo; tgt lowered to $187
- Johnson Controls (JCI) downgraded to Hold from Buy at Vertical Research; tgt $55
- Johnson & Johnson (JNJ) downgraded to Equal Weight from Overweight at Wells Fargo; tgt lowered to $163
- LyondellBasell (LYB) downgraded to Neutral from Buy at Citigroup; tgt lowered to $98
- Model N (MODN) downgraded to Neutral from Overweight at JP Morgan; tgt lowered to $25
- NETSTREIT (NTST) downgraded to Neutral from Outperform at Exane BNP Paribas; tgt $17
- NexPoint Real Estate Finance (NREF) downgraded to Mkt Perform from Outperform at Keefe Bruyette
- R1 RCM (RCM) downgraded to Neutral from Overweight at JP Morgan; tgt lowered to $11
- Shell plc (SHEL) downgraded to Neutral from Outperform at Exane BNP Paribas
- Trex (TREX) downgraded to Underweight from Equal Weight at Barclays; tgt raised to $74
- Visteon (VC) downgraded to Neutral from Outperform at Exane BNP Paribas; tgt $130
- Walker & Dunlop (WD) downgraded to Mkt Perform from Outperform at Keefe Bruyette; tgt raised to $105
- Western Midstream (WES) downgraded to Underperform from Buy at BofA Securities; tgt lowered to $27
- WPP plc (WPP) downgraded to Neutral from Overweight at JP Morgan
- Zurn Elkay Water Solutions (ZWS) downgraded to Sector Weight from Overweight at KeyBanc Capital Markets
-
Others:
- 10x Genomics (TXG) initiated with an Outperform at Wolfe Research; tgt $55
- ACADIA Pharmaceuticals (ACAD) initiated with a Buy at Citigroup; tgt $38
- ACELYRIN (SLRN) initiated with an Equal Weight at Wells Fargo; tgt $11
- Advance Auto (AAP) resumed with a Mkt Perform at William Blair
- Agilent (A) initiated with an Outperform at Wolfe Research; tgt $140
- Aris Water Solutions (ARIS) initiated with a Buy at Seaport Research Partners; tgt $15
- Alphabet (GOOG/L) named new Top Pick at JP Morgan
- Arcturus Therapeutics (ARCT) initiated with a Buy at Canaccord Genuity; tgt $90
- AutoZone (AZO) resumed with an Outperform at William Blair
- Axsome Therapeutics (AXSM) initiated with a Buy at Citigroup; tgt $125
- Bruker (BRKR) initiated with an Outperform at Wolfe Research; tgt $80
- Camping World (CWH) initiated with a Buy at ROTH MKM; tgt $30
- CAVA Group (CAVA) initiated with an Outperform at TD Cowen; tgt $46
- CCC Intelligent Solutions (CCCS) resumed with a Neutral at Citigroup; tgt $13
- Cricut (CRCT) initiated with a Neutral at Goldman; tgt $7
- Danaher (DHR) resumed with a Peer Perform at Wolfe Research
- Denali Therapeutics (DNLI) initiated with a Buy at Citigroup; tgt $32
- DoubleVerify (DV) initiated with an Overweight at Morgan Stanley; tgt $40
- Exact Sciences (EXAS) initiated with an Outperform at Wolfe Research; tgt $95
- Guardant Health (GH) initiated with a Peer Perform at Wolfe Research
- HilleVax (HLVX) initiated with a Buy at H.C. Wainwright; tgt $28
- Impinj (PI) initiated with a Positive at Susquehanna; tgt $100
- Illumina (ILMN) initiated with an Outperform at Wolfe Research; tgt $175
- Kanzhun Limited (BZ) initiated with an Overweight at JP Morgan; tgt $20
- Microsoft (MSFT) initiated with a Buy at Truist
- Myriad Genetics (MYGN) initiated with an Outperform at Wolfe Research; tgt $28
- Natera (NTRA) initiated with an Outperform at Wolfe Research; tgt $70
- Neurocrine Biosciences (NBIX) resumed with a Buy at William O'Neil
- Neurocrine Biosciences (NBIX) resumed with a Neutral at Citigroup; tgt $127
- Opera (OPRA) initiated with a Buy at Goldman; tgt $16.50
- Pacific Biosciences (PACB) initiated with a Peer Perform at Wolfe Research
- Qiagen (QGEN) initiated with a Peer Perform at Wolfe Research
- Revvity (RVTY) initiated with a Peer Perform at Wolfe Research
- Roblox (RBLX) initiated with an Overweight at Wells Fargo; tgt $49
- Sarepta Therapeutics (SRPT) resumed with a Buy at Citigroup; tgt $113
- Standex International (SXI) initiated with a Buy at DA Davidson; tgt $165
- Thermo Fisher (TMO) initiated with an Outperform at Wolfe Research; tgt $575
- Veralto (VLTO) initiated with a Peer Perform at Wolfe Research
- VIZIO (VZIO) initiated with a Buy at B. Riley Securities; tgt $11
- Xylem (XYL) initiated with an Outperform at Wolfe Research; tgt $127